DECODE ANNOUNCES NEW LEADERSHIP UPDATES 

May 2, 2025 | deCODE genetics, NEWS

Kari Stefánsson, M.D., Dr. Med., Tenure Ends; Two Distinguished Genetic Researchers in Iceland Appointed Co-Managing Directors  deCODE genetics today announced leadership changes. The tenure of Kari Stefánsson, M.D., Dr. Med., founder and chief executive officer of...

A rare missense variant in FRS3 associates with lower body mass index and protection against obesity

Mar 25, 2025 | NEWS

Scientists at deCODE genetics, a subsidiary of Amgen, and collaborators have published a study in Nature Communications reporting a rare missense variant in FRS3 that associates with decreased body mass index (BMI) and protection against obesity. This missense variant...

Rare loss-of-function variants in HECTD2 and AKAP11 confer a risk of bipolar disorder

Mar 25, 2025 | NEWS

Scientists at deCODE genetics, a subsidiary of Amgen, reveal today in Nature Genetics, associations between rare loss-of-function variants in two genes and bipolar disorder.Bipolar disorder is characterized by extreme mood swings, bouts of mania or hypomania, and...

Complete recombination map of the human-genome, a major step in genetics

Jan 22, 2025 | NEWS

Scientists at deCODE genetics/Amgen have constructed a complete map of how human DNA is mixed as it is passed down during reproduction. The map marks a major step in understanding genetic diversity and its impact on health and fertility. It continues 25 years of...

New AI method improves Gene Splicing Prediction

Dec 10, 2024 | NEWS

Scientists from deCODE genetics, a subsidiary of Amgen, and the University of Iceland have developed a new artificial intelligence method that enhances the accuracy of predicting RNA splicing, a fundamental process in gene regulation. The approach, named...